NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS Article

Wefel, Jeffrey, Pugh, Stephanie, Choucair, Ali et al. (2019). NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS . NEURO-ONCOLOGY, 21(Supplement_6), vi158-vi159. 10.1093/neuonc/noz175.663

cited authors

  • Wefel, Jeffrey; Pugh, Stephanie; Choucair, Ali; Fisher, Barbara; Fox, Sherry; Meyers, Christina; Ashby, Lynn; Mikkelsen, Tom; Glass, Jon; Yu, Michael; Howard, Steven; Movsas, Benjamin; Mehta, Minesh

authors

publication date

  • November 11, 2019

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Basic Behavioral and Social Science
  • Behavioral and Social Science
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi158

end page

  • vi159

volume

  • 21

issue

  • Supplement_6